Name: Latest research reports of Ipca Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Motilal Oswal

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer

1423.8000 19.40 (1.38%)

NSE Apr 21, 2025 15:31 PM

35.34% Gain from 52W Low

Volume: 163.7K

Ipca Laboratories Ltd.

14 Oct 2024

1423.80

1.38%

At an inflexion point

Buy: Ipca Laboratories Ltd.

Recommendation Target

Motilal Oswal

After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.

Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.